{"nct_id":"NCT05177770","title":"Study of SRF617 With AB928 (Etrumadenant) and AB122 (Zimberelimab) in Patients With Metastatic Castration Resistant Prostate Cancer","status":"TERMINATED","status_verified_date":"2025-04","start_date":"2022-01-17","start_date_type":"ACTUAL","primary_completion_date":"2023-04-05","primary_completion_date_type":"ACTUAL","completion_date":"2023-04-05","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["CHRS"]}